Effect of escalating doses of recombinant human granulocyte colony—stimulating factor (filgrastim) on circulating neutrophils in healthy subjects
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (4) , 722-736
- https://doi.org/10.1016/s0149-2918(98)80135-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Filgrastim (r-metHuG-CSF): the first 10 yearsBlood, 1996
- A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaBlood, 1993
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropeniaBlood, 1990
- Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.Journal of Clinical Oncology, 1989
- Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.Journal of Clinical Oncology, 1989
- GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.The Journal of Experimental Medicine, 1985
- Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.Proceedings of the National Academy of Sciences, 1985